Uncategorized

AstraZeneca Building Shanghai Production Plant to Support Cell Therapy Strategy

Published

on

The company is establishing commercial production capabilities to fuel plans to launch autologous CAR-T cell therapies in China.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version